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Abstract
Genome-wide association studies (GWAS) have now identified at least 2,000 common variants that appear associated with
common diseases or related traits (http://www.genome.gov/gwastudies), hundreds of which have been convincingly
replicated. It is generally thought that the associated markers reflect the effect of a nearby common (minor allele frequency
.0.05) causal site, which is associated with the marker, leading to extensive resequencing efforts to find causal sites. We
propose as an alternative explanation that variants much less common than the associated one may create ‘‘synthetic
associations’’ by occurring, stochastically, more often in association with one of the alleles at the common site versus the
other allele. Although synthetic associations are an obvious theoretical possibility, they have never been systematically
explored as a possible explanation for GWAS findings. Here, we use simple computer simulations to show the conditions
under which such synthetic associations will arise and how they may be recognized. We show that they are not only
possible, but inevitable, and that under simple but reasonable genetic models, they are likely to account for or contribute to
many of the recently identified signals reported in genome-wide association studies. We also illustrate the behavior of
synthetic associations in real datasets by showing that rare causal mutations responsible for both hearing loss and sickle cell
anemia create genome-wide significant synthetic associations, in the latter case extending over a 2.5-Mb interval
encompassing scores of ‘‘blocks’’ of associated variants. In conclusion, uncommon or rare genetic variants can easily create
synthetic associations that are credited to common variants, and this possibility requires careful consideration in the
interpretation and follow up of GWAS signals.
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Introduction
Efforts to fine map the causal variants responsible for genome-
wide association studies (GWAS) signals have been largely
predicated on the common disease common variant theory,
postulating a common variant as the culprit for observed
associations. This has led to extensive resequencing efforts that
have been largely unsuccessful [1–5]. Here, we explore the
possibility that part of the reason for this may be that the disease
class causing an observed association may consist of multiple low-
frequency variants across large regions of the genome—a
phenomenon we call synthetic association. For convenience, these
less common variants will be referred to here as ‘‘rare,’’ but we
emphasize that we use this term loosely, only to refer to variants
less common than those routinely studied in GWAS.
The basic idea of how synthetic associations emerge in this
model is illustrated in Figure 1, which shows how rare variants, by
chance, can occur disproportionately in some parts of a gene
genealogy. Any variant ‘‘higher up in the genealogy’’ that
partitions those parts of the genealogy containing more disease
variants than average will be identified as disease-associated. It is
well appreciated that a noncausal variant will show association
with a causal variant if the two are in strong linkage disequilibrium
(LD). We use the previously introduced term synthetic association [6],
however, to describe how such indirect association can occur
between a common variant and at least one and possibly many
rarer causal variants. Using the term synthetic as opposed to indirect
emphasizes that the properties of the association signal are very
different when the responsible variant or variants are much less
frequent than the marker that carries the signal, as we detail
below.
To assess the tendency of rare disease-causing variants to create
synthetic signals of association that are credited to single
polymorphisms that are much more common in the population
than the causal variants, we have simulated 10,000 haplotypes
based on a coalescent model in a region either with or without
recombination (Materials and Methods). We assumed that gene
variants that influence disease have an allele frequency between
0.005 and 0.02, which is generally below the range of reliable
detection (either by inclusion or indirect representation) using the
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baseline probability of disease of w for individuals with none of the
rare genetic risk factors. The presence of at least one rare risk allele
at the locus increased the probability of disease from w to c.W e
considered two values of w (0.01, 0.1) and chose values of the
penetrance c such that the genotypic relative risk (GRR) of the
rare causal variants varied incrementally between 2 and 6, where
GRR is the ratio c/w. These values were chosen to explore the
space around a GRR of 4, a threshold above which consistent
linkage signals would be expected [7]. We simulated scenarios with
one, three, five, seven, and nine rare causal variants.
Results
Across the conditions we have studied, not only is it possible to
achieve genome-wide significance for common variants when one
or more rare variants are the only contributors to disease, it is
often the likely outcome (Figure 2). Overall, 30% of the
simulations were able to detect an association with a common
SNP at genome-wide significance (p,10
28). Three factors—GRR,
sample size, and the number of rare causal variants—had a
notable impact on power to detect an association with a common
SNP. As expected, greater proportions of synthetic associations
were created when GRR increased for the rare causal variants and
when sample size increased. As the number of rare causal variants
increased, the probability of creating a synthetic association did as
well. One possible explanation for this increase due to increasing
the number of rare causal variants is that adding more causal
variants increases the size of the disease class, which is the
proportion of haplotypes that carry one or more disease alleles [8].
The size of the disease class varied in the simulations both because
the frequency of causal variants was allowed to vary, and because
the disease class increases on average with the number of causal
variants. To investigate the effect of the disease class on synthetic
associations, we separated the results by size of disease class and
found first that the larger the disease class the higher the chance of
a significant synthetic association. We also find, however, that
within a disease class size, the probability of significant synthetic
associations decreases with the number of causal variants
(Figure 3).
Importantly, association with the strongest causal variant in
individual simulations was more significant than with the strongest
common synthetic association in 98% of the simulations, and for
each combination of parameters, the proportion of simulations
with genome-wide significant associations was always higher for
the strongest causal variant than for synthetic associations when
testing for association with individual variants. Of particular
importance to note, except for the case of GRR=2, all conditions
considered here produced a nonnegligible proportion of simula-
tions with significant common variants. It is also noteworthy that
significant signals of association can be credited to common
variants even when there is only a single rare causal site. A control
simulation was run by testing the common variants from one
genealogy against phenotypes generated by a separate genealogy
with the same parameter settings and not a single test fell below
genome-wide significance of 10
28 for all simulations. This shows
that significant synthetic associations depend on the associations
that occur within a single gene genealogy (or correlated ones in a
recombination graph) and that sites undergoing free recombina-
tion cannot create genome-wide significant synthetic associations.
Intuitively, it seems obvious that when rare variants are the
cause of the associations, there should then be multiple common
variants that carry significant independent associations. To
evaluate this expectation, we took those genealogies that produced
a genome-wide significant association and asked what the strongest
association was when the top genome-wide significant association
was first incorporated in the model. We found that almost 40% of
genealogies with a genome-wide significant variant had secondary,
independent associations that also achieved genome-wide signif-
icance. We also found that fewer than 10% of genealogies had no
further significant associations (at a=0.05). These results demon-
strate a clear tendency of rare variants to create multiple
independent signals of synthetic association.
One essential question about synthetic associations is whether
they are expected to be robust to the presence of recombination.
Surprisingly, not only does recombination fail to eliminate
synthetic associations, but low rates of recombination can enhance
them compared with no recombination (Figure 2B). For example,
for GRR=4 and 9 risk alleles, and a sample size of 3,000 cases
and 3,000 controls, we find the proportion of trees showing
significance for zero recombination is 0.66. When we introduce a
recombination rate of 5610
25 (ten times the genome-wide
average for 500 bp) between segments, however, we find that
the proportion increases to 0.92. When recombination is increased
further, the expected decline in the synthetic association is
observed. Importantly, however, even at exceptionally high
recombination through the region (5610
24 between segments),
we find that almost 30% of the simulations show a significant
common variant, and recombination must increase to 5610
23 to
reduce the proportion to below 1%. Importantly, the simulations
involving recombination prohibit evaluation of any common
variant that has a rare causal site within the same segment. Thus
the synthetic associations emerging in these simulations occur
between sites that are separated by a minimum recombination
distance of that between segments, which is 1610
23 to 5610
23.I t
is counterintuitive that recombination would increase synthetic
associations since recombination reduces the average LD in a
region. The observation can be explained, however, by the effect
of recombination on the distribution of association amongst sites
within a genomic region. Although the average LD declines as
recombination increases, it is not known how higher moments
behave and these moments can influence the proportion of pairs of
sites that exceed some given threshold level of association.
We tested this as the explanation for the capacity of
recombination to enhance associations by directly evaluating the
mean and the variance of the association between rare and
Author Summary
It has long been assumed that common genetic variants of
modest effect make an important contribution to common
human diseases, such as most forms of cardiovascular
disease, asthma, and neuropsychiatric disease. Genome-
wide scans evaluating the role of common variation have
now been completed for all common disease using
technology that claims to capture greater than 90% of
common variants in major human populations. Surpris-
ingly, the proportion of variation explained by common
variation appears to be very modest, and moreover, there
are very few examples of the actual variant being
identified. At the same time, rare variants have been
found with very large effects. Now it is demonstrated in a
simulation study that even those signals that have been
detected for common variants could, in principle, come
from the effect of rare ones. This has important
implications for our understanding of the genetic archi-
tecture of human disease and in the design of future
studies to detect causal genetic variants.
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regions separated by a specified recombination rate. We calculated
the average pairwise association between rare and common
variants and also the variance of the pairwise LD between rare and
common variants in each simulation, and evaluated both these
parameters as a function of recombination. We found that
although the mean is nonincreasing, the variance first increases
then decreases (Figure 4), suggesting that increases in recombina-
tion can ‘‘widen’’ the distribution of LD among sites sufficiently to
increase the density in the tail and thereby create stronger
synthetic associations.
These patterns make clear that so long as a given genomic
region has one or more rare variants that contribute to disease,
these rare variants can generate synthetic associations that are
observed in much more common polymorphisms. Under ideal
conditions for such synthetic associations, they can be detected
with sample sizes far smaller than those routinely used in
GWAS. Under less ideal conditions (for example, higher
prevalence attributable to environment or to other genetic
factors outside of the locus being considered or lower
penetrance for the local rare variants), the sample size must
be larger. One essential quality of synthetic associations is that
although they are often likely to be created when multiple rare
variants exist in a region, there are certain conditions under
which very little association will be detected even with very large
sample sizes and large effects of the causal variants because
causal alleles will segregate to opposite common alleles. In other
words, no common variant will be able to partition the rare
variants on a genealogy to create a large enough imbalance to
create association. We also investigated trends in association
with causal variants and found that even though our model
specified that only derived alleles at causal sites are deleterious,
more than a third of the most highly associated common SNPs
showed a higher penetrance for the ancestral allele. This result
follows observed patterns [9]. Another important trend is that if
only rare variants are contributing to the disease class in a
region, the risk allele frequency of the most significant synthetic
association will tend toward the low end of the distribution of
more common allele frequencies (median=0.10), although over
20% of genome-wide significant synthetic associations had a risk
allele frequency above 0.25 (Figure 5). Of course, this trend is
noted when all common variants in a region are included, which
is not the case with the available commercial genotyping chips,
which have a greater probability of including more common
variants. In this case, the skew towards lower-frequency variants
would be less.
We next attempted to determine the expected genomic
distances over which rare variants could create synthetic
associations. To do so, we simulated a 10-Mb region with a
typical recombination rate (1 cM/Mb), nine rare causal variants,
Figure 1. Example genealogies showing causal variants and the strongest association for a common variant. (A) A genealogy with
10,000 original haplotypes was generated with 3,000 cases and 3,000 controls, genotype relative risk (c)=4, and nine causal variants. The branches
containing the strongest synthetic association are indicated in blue. The branches containing the rare causal variants are in red. (B) A second
genealogy was generated using the same parameters. These genealogies demonstrate two scenarios with genome-wide significant synthetic
associations: the first (upper genealogy) had a high risk allele frequency (RAF=0.49), and the second (lower genealogy) had a low RAF (0.08).
doi:10.1371/journal.pbio.1000294.g001
Figure 2. The proportion of simulations with a variant of genome-wide significance. Results for rare variants are shown in red; for the top
hit among common variants, results are shown in black; and in blue are the results for the next best hit for common variants after including the top
hit in the regression model. At the bottom of each graph, the simulation parameters are represented graphically. Results across all parameters with
no recombination are shown in (A) with the shaded region representing the effect size at which linkage analysis is expected to begin generating
consistent signals (GRR=4). Results for simulations that included recombination are shown in (B). The shaded region in (B) is the same as the shaded
region in (A), with the rate of recombination for the same parameters increasing along the x-axis.
doi:10.1371/journal.pbio.1000294.g002
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the most distal causal variant that was confirmed to actually
contribute to the signal of synthetic association. We did this by
finding the most distal variant that resulted in a minimum of a
one-log drop in p-value when its effect was statistically removed (by
incorporation as a covariate into the regression). We found that
when a synthetic association reached genome-wide significance,
the most distant causal variant that affected the significance of the
synthetic association was closer than 2 Mb from a synthetic
association in fewer than 13% of the simulations and at least 9 Mb
away in 4% of the simulations. The median distance of the most
distant causal variant was 5 Mb. A simulated Manhattan plot
showing a 10-Mb region with average recombination and nine
causal variants with GRR=4 shows an example of a signature
created by synthetic association (Figure 6).
Finally, we evaluated the genomic pattern of synthetic
associations using two real-world examples: hearing loss and sickle
cell anemia. These two examples represent two possible extremes
for synthetic associations. Sickle cell anemia is a serious Mendelian
disease in which the body makes sickle-shaped red blood cells. The
Figure 3. The proportion of simulations with a variant of genome-wide significance separated by disease class. Increasing the number
of causal variants generally increases the probability of creating synthetic associations by increasing the size of the disease class without increasing
the allele frequency of causal variants. Within disease class, increasing the number of causal variants decreases the probability of creating synthetic
association.
doi:10.1371/journal.pbio.1000294.g003
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prevalence among African Americans in the United States is
approximately 1 in 600 [10]. It is known to be caused by
autosomal recessive mutations in HBB, and the frequency of the
most common causal variant (Hb S allele) is ,3.6% in Americans
of African ancestry [11]. In comparison, hearing loss is a com-
plex human disease, occurring in one per 1,000 newborns on
average [12]. More than two dozen causal genes have been
identified for autosomal recessive nonsyndromic hearing loss
[13,14], but mutations in the GJB2/GJB6 locus account for
about half of the cases of European ancestry [12,15]. Among
hundreds of known causal mutations in the GJB2/GJB6 locus
[14], the 35delG mutation in GJB2 is the most common, with an
allele frequency of 1.25% in European Americans [16], but
hundreds of other point mutations in GJB2 as well as a 342-kb
deletion encompassing GJB6 also represent known causal variants
[17,18].
For sickle cell anemia, a total of 179 SNPs reached genome-wide
significance (p,5610
28), encompassing an ,2.5-Mb region on
chromosome 11p15.4 (from 3.59 Mb for rs12422109 to 5.98 Mb
for rs997433). The region contains dozens of genes and dozens of
visually discernable LD blocks in HapMap YRI population. The
top association signal (rs7120391, p=1.1610
2136) is 9 kb from
OR51V1, which is very near the causal gene, HBB (Figure 7).
Clearly, highly significant association signals can travel across
multiple LD blocks to distant genomic regions.
The three most significantly associated SNPs for hearing loss are
all located at the GJB2/GJB6 locus on 13q12.1 (Figure 8),
including rs870729 near GJB6 (p=3.38610
211, OR: 1.69),
rs3751385 within GJB2 (p=1.50610
29, OR: 1.63), and
rs7329467 within GJA3 (p=6.87610
28, OR: 1.68). The three
SNPs have weak LD with each other (pairwise r
2 values range from
0.02 to 0.62), but all of them are common variants. For example,
rs870729 has a minor allele frequency (MAF) of 18.7% in controls
and 28.0% in cases. To evaluate the independence of the
association signals from the three SNPs, we tested association
again by incorporating rs870729 in a logistic regression model, yet
still found residual association for rs7329467 (p=4.3610
26), but
not rs3751385 (p=0.33), consistent with the expectations derived
Figure 4. Mean and variance of r
2 between rare and common sites as a function of rate of recombination. A total of 100,000 simulations
of two loci with multiple variants in each loci show how the mean and variance of estimates of r
2 between rare and common variants are affected by
recombination. Although the mean is a nonincreasing function of recombination, the variance increases then decreases, which shows why the
maximum r
2 between rare and common variants can increase with low amounts of recombination in a region.
doi:10.1371/journal.pbio.1000294.g004
Figure 5. Allele frequency distributions of all HapMap SNPs
(black), Illumina 1M SNPs (blue), and GWAS associations in
CEU (red), and simulated synthetic associations (green). The
allele frequencies show both minor and major allele frequencies. GWAS
associations have a clear tendency towards the center, representing
greater power to detect association with variants with higher minor
allele frequencies. CEU=population of western European ancestry.
doi:10.1371/journal.pbio.1000294.g005
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been extensively resequenced in numerous studies, and there is no
common causal variant at the locus with ,18.7% allele frequency
similar to rs870729. Therefore, rare variants at the locus create
multiple independent association signals captured by common
tagging SNPs.
Figure 6. Simulated Manhattan plots in a 10-Mb region. (A) This region has nine rare causal variants selected at random with GRR=4 and
3,000 cases and 3,000 controls. (B) The same region with permuted phenotypes shows what the region would look like without any association.
doi:10.1371/journal.pbio.1000294.g006
Figure 7. The 2.5-Mb genomic region on chr11p15.4 containing 179 genome-wide significant synthetic associations with sickle cell
anemia in African Americans. The 2log10(p) values for all genome-wide significant SNPs were displayed in the upper track, whereas the LD
patterns based on HapMap YRI (Yoruba people of Ibadan, Nigeria) population is displayed in the lower track. The region contains dozens of genes
spanning several discernible LD blocks.
doi:10.1371/journal.pbio.1000294.g007
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These results show that a large proportion of genomic regions
that harbor one or more rare variants that contribute to disease is
likely to create ‘‘synthetic’’ signals of association [6]. If the region
carries an excessively large number of causal variants, this
expectation decreases, but for intermediate numbers of (causal)
rare variants, detection of many such regions appears inevitable
due largely to the fact that increasing the number of rare causal
variants increases the size of the disease class in that region.
Separately considering the number of causal variants and the
proportion of alleles that are disease causing (the disease class)
Figure 8. Overview of the GJB2/GJB6 locus on 13q12.11 in the hearing loss GWAS. The three most significantly associated SNPs have weak
LD between each other. Although the most common causal variants (35delG) within GJB2 has a frequency of only 1.25% in European Americans, the
locus can still be identified by GWAS with common tagging SNPs.
doi:10.1371/journal.pbio.1000294.g008
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synthetic associations. The intuition for this is obvious. Even when
the frequency of disease-causing variants is very low individually,
as the disease class grows, collectively they come closer to the
frequency of common variants, allowing the possibility of a strong
signal to be generated for one of the common variants. This is only
prohibited when the causal variants are so numerous as to be
distributed roughly evenly through the genealogy (or if an even
distribution appears by chance for smaller numbers of causal
variants).
In considering the likelihood of rare variants creating a large
disease class, it is essential to appreciate that signals can combine
in the face of considerable recombination. This makes clear that
the ‘‘locus’’ associated with GWAS signals may be far larger than
has often been assumed.
We also note that the apparent size of the disease class is not a
good guide as to the number of causal variants responsible. Even if
the disease class is quite large, it is easily possible that it consists of
only rare variants if there are a relatively large number of rare
causal variants and these could be spread very broadly over
genome regions stretching into the megabases. With respect to the
size of the disease class, our simulations highlight the counterin-
tuitive result that, under some genetic models, increases in the
number of causal mutations at a locus can increase the probability
of a synthetic association.
Although our simulations only show that synthetic associations
are likely to occur, coupling this demonstration with the available
data does suggest that some of the reported associations are likely
to be due to this effect, and many more may be enhanced by the
signal of surrounding rare causal variants. First, despite consider-
able efforts, the vast majority of genome-wide associations have
never been tracked to causal sites, even though many surrounding
regions have been extensively resequenced [2–4]. If all of the
responsible variants were common SNPs, one might expect that
more clear evidence of causation would have been identified by
now for a nontrivial number of common variants. Although this
expectation is valid for common causal variants, because we know
roughly where to look in the genome, this does not hold for
synthetic associations due to rare variants, which may reside at a
considerable distance from the associated common variants.
Second, it is now known that rare variants contribute to common
diseases, and that cases that carry the rare high-penetrant
contributors to disease often have ‘‘typical’’ clinical presentations
[19–21]. On balance, therefore, our results suggest that even
though the apparent impact of common variants is only modest for
many traits [6,22,23], this impact may have been systematically
overestimated [24]. It is worth emphasizing that the alternative
explanation provided here makes clear, testable predictions. As
noted, in a model of synthetic associations, regions that show
significant effects for common variants will often consistently
show significant residual independent effects after the effect of the
most important variant has been accounted for. Second, since
rare variants are much more likely to be population specific,
synthetic associations are expected to be inconsistent across
population groups. In fact, a number of recent studies have
confirmed differences in effect between populations [24–35].
Table 1 lists variants from these studies in which the point estimate
for a follow-up study in a separate population fell outside the 95%
confidence interval for the odds ratio of the original study. This
includes 13 variants and odds ratios with confidence intervals for
the population in which association was first discovered (12
European and one Japanese) and 20 odds ratios for subsequent
tests in separate populations, consisting of eight tests in African
Americans (seven not significant and one significant in the
opposite direction), four tests in Japanese (one not significant
and three significant in the same direction), four tests in Koreans
(one not significant and three significant in the same direction),
two tests in the Indian subcontinent (two not significant), one test
in Europeans (not significant), and one in Chinese (not significant).
Although it is possible that many of these differences are related to
differences in LD (association) between markers and causal sites,
genetic or environmental interactions, or simply genetic hetero-
geneity, it appears likely that many of these differences are due to
multiple underlying rare variants that create different synthetic
effects in the populations. There are also likely to be other
diagnostics of synthetic associations observable in GWAS data. For
example, one would expect distinctive extended haplotypes to be
enriched in cases relative to controls in large regions surrounding
GWAS signals that are synthetic (K. Wang, S. P. Dickson, C. A.
Stolle, I. D. Krantz, D. B. Goldstein et al., unpublished data).
Perhaps most importantly, the observation that association
statistics are stronger for the causal sites in the vast majority of
cases implies that in many cases, it should be possible to identify
candidate causal sites using whole-genome sequence data
surrounding GWAS signals and evaluate these for association.
When the association is synthetic, association statistics would be
expected to strengthen considerably when the correct causal sites
are assayed.
There are also practical implications related to finding the
variants responsible for observed associations. Perhaps the most
important of these is that targeted sequencing within a ‘‘block’’ of
LD surrounding GWAS discoveries is often not expected to
identify the causal sites. Because modest amounts of recombina-
tion can enhance synthetic associations, and because recombina-
tion must be exceptionally high to eliminate the possibility of
genome-wide significant associations, one or more of the
responsible causal sites could be a very considerable distance
from the common variant showing a signal of association. This
possibility is starkly illustrated by the sickle cell anemia example in
which genome-wide significant synthetic associations span
,2.5 Mb around the causal mutation, although heterosis may
also influence this result. This possibility suggests that efforts to
identify causal variants responsible for GWAS signals that
concentrate on a region of high LD surrounding the implicated
variant are not well motivated and are likely to miss many and
perhaps most of any rare variants that contribute to synthetic
associations (see, for example, [5]). The distance over which
synthetic associations occur also offers an alternative explanation
to the increasingly common observation of rare variants that occur
within the vicinity of a GWAS signal but cannot explain that signal
entirely. A simple explanation for such observations is that
extending the sequencing to at least 4 Mb and ideally up to 10 Mb
around the GWAS signal would pick up other rare variants. In
some cases, identifying all the contributing rare variants may
explain all of the original signal, whereas in other cases, there
could be a combination of rare and common variants contributing.
In addition, if synthetic associations are responsible for many of
the observed signals, then sequencing in a small number of control
samples (even over a much broader genomic region) is also
unlikely to succeed. Under our model, the causal sites are both
rare and relatively high-penetrant contributors to disease, and will
therefore be unlikely to be detected in a small number of control
samples. Finally, the focus of attention on genes that are near
GWAS signals may be incomplete or misleading in that the actual
causal sites may occur in many different genes surrounding the
implicated common variant. It is also worth emphasizing that as
few as one or two rare variants, at much lower frequency than
the associated common SNP, can create a significant synthetic
Rare Variants in Synthetic Genome-Wide Association
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that carry the ‘‘at risk’’ common variant might miss entirely the
causal rare variants even if the correct genome region is
resequenced. These considerations argue for caution in efforts to
resequence around genome-wide associations and argue instead
that genome-wide sequencing in carefully phenotyped cohorts
might be a better use of resources.
It has been suggested that rare high-penetrant variants would
produce a signal inconsistent with those observed in many
common traits in favor of models with thousands of common
variants with marginal penetrance [36]. We have shown that
multiple rare variants in a region are capable of acting over large
distances to create associations in common variants similar to
observed associations. A key point is that multiple rare causal
variants may be causing the observed associations, therefore a
single haplotype would be insufficient to explain such associations.
Ultimately, the proportion of GWAS signals that is due to
common versus rare variants is a question that can only be
resolved empirically. Our analyses simply illustrate that in
following up GWAS signals, the possibility of synthetic
associations must be taken into account. If it were true that
many signals were synthetic in nature, however, one interesting
and potentially encouraging implication of these results is that
some of the very modest associations emerging from genome-
wide associations may in fact be pointers to rare variants of
much larger effect that could be directly informative about
disease pathophysiology or be sufficiently high penetrance to be
of useful predictive value.
Table 1. List of variants in recent GWAS showing evidence of a difference in effect between populations.
RAF Sample Size
Trait SNP Ethnicity OR CI Control Case Control/Case
T2D rs5015480 European 1.13 1.08 1.17 0.425 0.379 17,968/14,586
African American 0.95 0.83 1.08 0.633 0.621 1,054/993
T2D ra9300039 European 1.48 1.28 1.71 0.892 0.924 2,432/2,376
African American 0.42 0.19 0.91 0.889 0.884 1,054/993
Japanese 1.05 0.94 1.17 0.300 0.350 1,576/1,844
T2D rs8050136 European 1.23 1.18 1.32 0.398 0.455 8,284/5,681
African American 1.02 0.90 1.15 0.446 0.452 1,054/993
Korean 0.89 0.70 1.14 0.140 0.129 502/908
T2D rs4402960 European 1.18 1.08 1.28 0.304 0.341 2,432/2,376
African American 0.98 0.87 1.11 0.525 0.528 1,054/993
T2D rs7754840 European 1.12 1.03 1.22 0.360 0.387 2,432/2,376
Korean 1.77 1.50 2.10 0.392 0.332 502/908
Japanese 1.28 1.17 1.41 0.410 0.470 1,576/1,844
T2D rs17044137 European 1.16 1.10 1.22 0.230 0.270 2,432/2,376
African American 0.98 0.86 1.12 0.582 0.615 1,054/993
T2D rs11037909 European 1.27 0.97 1.57 0.729 0.760 2,432/2,376
African American 0.94 0.79 1.13 0.862 0.859 1,054/993
T2D rs1081161 European 1.20 1.07 1.36 0.850 0.872 2,432/2,376
Korean 1.47 1.23 1.75 0.558 0.639 502/908
Indian Subcontinent 0.78 0.56 1.09 0.912 0.890 516/295
T2D rs1111875 European 1.10 1.01 1.19 0.522 0.546 2,432/2,376
Korean 1.43 1.18 1.72 0.300 0.360 502/908
Indian Subcontinent 0.93 0.77 1.12 0.465 0.447 514/367
Japanese 1.27 1.14 1.40 0.280 0.330 1,576/1,844
T2D rs7923837 European 1.11 1.02 1.20 0.596 0.622 2,894/2,617
Japanese 1.27 1.13 1.43 0.190 0.220 1,576/1,844
Osteoarthritis rs12885713 Japanese 1.25 1.06 1.49 0.295 0.344 1,006/426
European 1.01 0.88 1.16 0.582 0.579 752/920
Chinese 1.00 0.71 1.41 0.205 0.205 210/183
Breast Cancer rs1219648 European 1.23 1.03 1.46 0.420 0.470 697/528
African American 0.84 0.64 1.09 0.450 0.420 427/157
Breast Cancer rs2981582 European 1.26 1.04 1.53 0.430 0.470 697/528
African American 0.80 0.49 1.08 0.520 0.460 427/157
Included are 13 variants and odds ratios with confidence intervals for the population in which association was first discovered, and 20 odds ratios for subsequent tests
in separate populations in which the point estimate for the odds ratio in the follow-up study fell outside the confidence interval of the original study.
RAF, risk allele frequency.
doi:10.1371/journal.pbio.1000294.t001
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For the primary simulation, two simulated haplotypes were
randomly selected with replacement for each individual, and
sufficient individuals were generated to simulate the desired
number of cases and controls. Case/control status was designated
based on the assigned risk, and equal numbers of cases and
controls were selected for association testing. We tested all
common variants in the genealogy for association with disease
status, where common was defined by a minor allele frequency of
0.05 or greater. Thus we exclude any variant that is actually
disease causing and focus on those that are generally represented
directly or indirectly in the current genome-wide genotyping
platforms [37]. Association tests were performed by comparing
1,000, 2,000, or 3,000 each of cases and controls, and we screened
for common variants with p-values less than 10
28, a now-typical
threshold for genome-wide significance [1]. We defined a single
‘‘simulation’’ as follows. A random gene genealogy was drawn with
mutations distributed along the genealogy, and disease-causing
mutations were assigned at random from those variants that were
in the allowed frequency range. Then cases and controls were
sampled as described, and the common variants screened for
association. We then determined the proportion of such
simulations that resulted in a genome-wide significant signal being
credited to at least one of the common variants in the genealogy.
Genealogical trees were simulated using GENOME with an
effective population size of 10,000 and a mutation rate of 10
28 in a
100-kb region. When recombination was simulated, 200 fragments
of 500 bp each were used with recombination occurring between
each fragment [38]. Trees were drawn using Dendroscope [39].
p-Values were obtained using logistic regression on the case-
control status under an additive model. Odds ratios (for the
common variants) were estimated using the b term from the
logistic regression. A second p-value reported for common variants
was based on a logistic regression, with the most strongly
associated common variant as a covariate in the model to assess
residual association after discounting the strongest synthetic
association.
For both disease association studies, we performed a standard
GWAS using Illumina HumanHap550 BeadChip with over
,550,000 SNPs, which represent common tagging variants and
do not include any of the disease-causing mutations for either
condition. We carried out a standard association test on all
markers on the chip passing default quality control measures
(minor allele frequency .5%, Hardy-Weinberg equilibrium p-
value .1610
26, SNP call rate .95%), using the PLINK software
[40]. For the sickle cell anemia GWAS, we compared 194 cases
and 7,407 controls of inferred African ancestry via multidimen-
sional scaling, with a genomic control inflation factor of 1.01. For
hearing loss, we performed a GWAS on 418 cases and 6,892
control subjects, all of whom were of genetically inferred European
ancestry via multidimensional scaling, with a genomic control
inflation factor of 1.02.
Author Contributions
The author(s) have made the following declarations about their
contributions: Conceived and designed the experiments: SPD DBG.
Performed the experiments: SPD HH. Analyzed the data: SPD KW.
Contributed reagents/materials/analysis tools: IK. Wrote the paper: SPD
KW HH DBG.
References
1. McCarthy MI, Hirschhorn JN (2008) Genome-wide association studies:
potential next steps on a genetic journey. Hum Mol Genet 17: R156–165.
2. Lowe CE, Cooper JD, Brusko T, Walker NM, Smyth DJ, et al. (2007) Large-scale
genetic fine mapping and genotype-phenotype associations implicate polymor-
phism in the IL2RA region in type 1 diabetes. Nat Genet 39: 1074–1082.
3. Burfoot RK, Jensen CJ, Field J, Stankovich J, Varney MD, et al. (2008) SNP
mapping and candidate gene sequencing in the class I region of the HLA
complex: searching for multiple sclerosis susceptibility genes in Tasmanians.
Tissue Antigens 71: 42–50.
4. Hafler JP, Maier LM, Cooper JD, Plagnol V, Hinks A, et al. (2009) CD226
Gly307Ser association with multiple autoimmune diseases. Genes Immun 10:
5–10.
5. Deloukas P on behalf of the Wellcome Trust Case Control Consortium (2008)
High throughput approaches to fine mapping in regions of confirmed
association. Presentation at the 58th Annual Meeting of the American Society
of Human Genetics, November 13, 2008; Philadelphia, Pennsylvania.
6. Goldstein DB (2009) Common genetic variation and human traits. N Engl J Med
360: 1696–1698.
7. Risch N, Merikangas K (1996) The future of genetic studies of complex human
diseases. Science 273: 1516–1517.
8. Reich DE, Lander ES (2001) On the allelic spectrum of human disease. Trends
Genet 17: 502–510.
9. Gibson G, Goldstein DB (2007) Human genetics: the hidden text of genome-
wide associations. Curr Biol 17: R929–932.
10. Gladwin MT, Vichinsky E (2008) Pulmonary complications of sickle cell disease.
N Engl J Med 359: 2254–2265.
11. Ashley-Koch A, Yang Q, Olney RS (2000) Sickle hemoglobin (HbS) allele and
sickle cell disease: a HuGE review. Am J Epidemiol 151: 839–845.
12. Tekin M, Arnos KS, Pandya A (2001) Advances in hereditary deafness. Lancet
358: 1082–1090.
13. Petersen MB, Willems PJ (2006) Non-syndromic, autosomal-recessive deafness.
Clin Genet 69: 371–392.
14. Hilgert N, Smith RJ, Van Camp G (2009) Forty-six genes causing nonsyndromic
hearing impairment: which ones should be analyzed in DNA diagnostics? Mutat
Res 681: 189–196.
15. Kenneson A, Van Naarden Braun K, Boyle C (2002) GJB2 (connexin 26)
variants and nonsyndromic sensorineural hearing loss: a HuGE review. Genet
Med 4: 258–274.
16. Green GE, Scott DA, McDonald JM, Woodworth GG, Sheffield VC, et al.
(1999) Carrier rates in the midwestern United States for GJB2 mutations causing
inherited deafness. JAMA 281: 2211–2216.
17. Marlin S, Feldmann D, Blons H, Loundon N, Rouillon I, et al. (2005) GJB2 and
GJB6 mutations: genotypic and phenotypic correlations in a large cohort of
hearing-impaired patients. Arch Otolaryngol Head Neck Surg 131: 481–487.
18. del Castillo I, Villamar M, Moreno-Pelayo MA, del Castillo FJ, Alvarez A, et al.
(2002) A deletion involving the connexin 30 gene in nonsyndromic hearing
impairment. N Engl J Med 346: 243–249.
19. Stefansson H, Rujescu D, Cichon S, Pietilainen OP, Ingason A, et al. (2008)
Large recurrent microdeletions associated with schizophrenia. Nature 455:
232–236.
20. Spencer KL, Hauser MA, Olson LM, Schmidt S, Scott WK, et al. (2008)
Deletion of CFHR3 and CFHR1 genes in age-related macular degeneration.
Hum Mol Genet 17: 971–977.
21. Nejentsev S, Walker N, Riches D, Egholm M, Todd JA (2009) Rare variants of
IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes.
Science 324: 387–389.
22. Wellcome Trust Case Control Consortium (2007) Genome-wide association
study of 14,000 cases of seven common diseases and 3,000 shared controls.
Nature 447: 661–678.
23. Maher B (2008) Personal genomes: the case of the missing heritability. Nature
456: 18–21.
24. Rebbeck TR, DeMichele A, Tran TV, Panossian S, Bunin GR, et al. (2009)
Hormone-dependent effects of FGFR2 and MAP3K1 in breast cancer
susceptibility in a population-based sample of post-menopausal African-
American and European-American women. Carcinogenesis 30: 269–274.
25. Lewis JP, Palmer ND, Hicks PJ, Sale MM, Langefeld CD, et al. (2008)
Association analysis in African Americans of European-derived type 2 diabetes
single nucleotide polymorphisms from whole-genome association studies.
Diabetes 57: 2220–2225.
26. Lei SF, Yang TL, Tan LJ, Chen XD, Guo Y, et al. (2009) Genome-wide
association scan for stature in Chinese: evidence for ethnic specific loci. Hum
Genet 125: 1–9.
27. Lee YH, Kang ES, Kim SH, Han SJ, Kim CH, et al. (2008) Association between
polymorphisms in SLC30A8, HHEX, CDKN2A/B, IGF2BP2, FTO, WFS1,
CDKAL1, KCNQ1 and type 2 diabetes in the Korean population. J Hum
Genet 53: 991–998.
28. Mototani H, Mabuchi A, Saito S, Fujioka M, Iida A, et al. (2005) A functional
single nucleotide polymorphism in the core promoter region of CALM1 is
associated with hip osteoarthritis in Japanese. Hum Mol Genet 14: 1009–1017.
29. Loughlin J, Sinsheimer JS, Carr A, Chapman K (2006) The CALM1 core
promoter polymorphism is not associated with hip osteoarthritis in a United
Kingdom Caucasian population. Osteoarthritis Cartilage 14: 295–298.
Rare Variants in Synthetic Genome-Wide Association
PLoS Biology | www.plosbiology.org 11 January 2010 | Volume 8 | Issue 1 | e100029430. Shi D, Ni H, Dai J, Qin J, Xu Y, et al. (2008) Lack of association between the
CALM1 core promoter polymorphism (216C/T) and susceptibility to knee
osteoarthritis in a Chinese Han population. BMC Med Genet 9: 91.
31. Kao WH, Klag MJ, Meoni LA, Reich D, Berthier-Schaad Y, et al. (2008)
MYH9 is associated with nondiabetic end-stage renal disease in African
Americans. Nat Genet 40: 1185–1192.
32. Sanghera DK, Ortega L, Han S, Singh J, Ralhan SK, et al. (2008) Impact of
nine common type 2 diabetes risk polymorphisms in Asian Indian Sikhs:
PPARG2 (Pro12Ala), IGF2BP2, TCF7L2 and FTO variants confer a significant
risk. BMC Med Genet 9: 59.
33. Dutta S, Sinha S, Ghosh S, Chatterjee A, Ahmed S, et al. (2008) Genetic
analysis of reelin gene (RELN) SNPs: no association with autism spectrum
disorder in the Indian population. Neurosci Lett 441: 56–60.
34. Myles S, Davison D, Barrett J, Stoneking M, Timpson N (2008) Worldwide
population differentiation at disease-associated SNPs. BMC Med Genomics 1:
22.
35. Horikawa Y, Miyake K, Yasuda K, Enya M, Hirota Y, et al. (2008) Replication
of genome-wide association studies of type 2 diabetes susceptibility in Japan.
J Clin Endocrinol Metab 93: 3136–3141.
36. Purcell SM, Wray NR, Stone JL, Visscher PM, O’Donovan MC, et al. (2009)
Common polygenic variation contributes to risk of schizophrenia and bipolar
disorder. Nature 460: 748–752.
37. Li M, Li C, Guan W (2008) Evaluation of coverage variation of SNP chips for
genome-wide association studies. Eur J Hum Genet 16: 635–643.
38. Liang L, Zollner S, Abecasis GR (2007) GENOME: a rapid coalescent-based
whole genome simulator. Bioinformatics 23: 1565–1567.
39. Huson DH, Richter DC, Rausch C, Dezulian T, Franz M, et al. (2007)
Dendroscope: an interactive viewer for large phylogenetic trees. BMC
Bioinformatics 8: 460.
40. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, et al. (2007)
PLINK: a tool set for whole-genome association and population-based linkage
analyses. Am J Hum Genet 81: 559–575.
Rare Variants in Synthetic Genome-Wide Association
PLoS Biology | www.plosbiology.org 12 January 2010 | Volume 8 | Issue 1 | e1000294